US 8506947
Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell
granted A61KA61K2039/5156A61K48/00
Quick answer
US patent 8506947 (Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/5156, A61K48/00